This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohshiro, K. Articles by Kumar, R. Search for Related Content PubMed PubMed Citation Articles by Ohshiro, K. Articles by Kumar, R.

Identifying the Estrogen Receptor Coactivator PELP1 in Autophagosomes

Departments of ¹ Molecular and Cellular Oncology, ² Neurosurgery, and ³ Pathology, The University of Texas M. D. Anderson Cancer Center; ⁴ Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas; ⁵ BD Biosciences, San Diego, California; and ⁶ Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, San Antonio, Texas

Requests for reprints: Rakesh Kumar, Department of Molecular and Cellular Oncology, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 108, Houston, TX 77030. Phone: 713-745-3558; Fax: 713-745-3792; E-mail: rkumar{at}mdanderson.org or Adel K. El-Naggar, Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030. E-mail: el-naggar{at}mdanderson.org.

Resveratrol, a well-established phytoestrogen and chemopreventive agent, has gained much attention among oncologists because it can act as both estrogen receptor agonist and antagonist, depending on dosage and cell context. It is increasingly accepted that steroidal receptor coregulators may also function in the cytoplasmic compartment. Deregulation and altered localization of these coregulators could influence target gene expression and participate in the development of hormone-responsive cancers. Proline-, glutamic acid–, and leucine-rich protein-1 (PELP1), a novel estrogen receptor (ER) coactivator, plays an important role in the genomic and nongenomic actions of ER. Furthermore, recent studies have shown that differential compartmentalization of PELP1 could be crucial in modulating sensitivity to tamoxifen. In this study, we investigated the role of PELP1 in resveratrol-induced autophagy in lung cancer and salivary gland adenocarcinoma cell lines. Resveratrol reversibly inhibited the growth of these cancer cell lines and induced autophagy, as evidenced by microtubule-associated protein 1 light chain 3 (LC3) up-regulation in a time-dependent and 3-methyladenine–sensitive manner. Confocal microscopic analysis showed that resveratrol induced PELP1 accumulation in autophagosomes with green fluorescent protein-LC3. The intermediary molecule involved in PELP1 accumulation in resveratrol-induced autophagosomes is hepatocyte growth factor–regulated tyrosine kinase substrate (HRS), a trafficking molecule that binds to PELP1. These results identify PELP1 for the first time in autophagosomes, implying that both PELP1 and HRS reallocate to autophagosomes in response to resveratrol treatment, which might be important in the process of autophagy in the cancer cells. [Cancer Res 2007;67(17):8164–71]

This article has been cited by other articles:

				A. Puissant, G. Robert, N. Fenouille, F. Luciano, J.-P. Cassuto, S. Raynaud, and P. Auberger Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation Cancer Res., February 1, 2010; 70(3): 1042 - 1052. [Abstract] [Full Text] [PDF]

				S. Slavikova, S. Ufaz, T. Avin-Wittenberg, H. Levanony, and G. Galili An autophagy-associated Atg8 protein is involved in the responses of Arabidopsis seedlings to hormonal controls and abiotic stresses J. Exp. Bot., October 3, 2008; (2008) ern244v1. [Abstract] [Full Text] [PDF]

				K. Singletary and J. Milner Diet, Autophagy, and Cancer: A Review Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1596 - 1610. [Abstract] [Full Text] [PDF]